Short-term exposure to an experimental drug reverses age-related memory decline and cognitive deficits in mice. The drug, ISRIB, has previously shown beneficial effects in treating memory loss associated with TBI and other neurological disorders.
Short-term exposure to an experimental drug reverses age-related memory decline and cognitive deficits in mice. The drug, ISRIB, has previously shown beneficial effects in treating memory loss associated with TBI and other neurological disorders.
Share this Article
Recommended